COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,846 Articles (22,553 medRxiv, 8,293 bioRxiv)

Most recent first Previous |  Page 2119: Articles 21181-21190  | Next

Recovery of monocyte exhaustion is associated with resolution of lung injury in COVID-19 convalescence.
Scott, N. A., Knight, S. B., Pearmain, L., Brand, O., Morgan, D. J., Jagger, C., Khan, S., Hackney, P., Smith, L., Menon, M., Konkel, J., Shuwa, H. A., Franklin, M., Kaestele, V., Harbach, S., Brij, S., Ustianowski, A., Uriel, A., Lindergard, G., Diar Bakerly, N., Dark, P., Mathioudakis, A., Gray, K., Lord, G., Felton, T., Brightling, C., Ho, L.-P., NIHR Respiratory TRC, , CIRCO, , Piper Hanley, K., Simpson, A., Grainger, J. R., Hussell, T., Mann, E. R.
10.1101/2020.10.10.20207449 — Posted: 2020-10-16
TREATMENT PROFILES AND CLINICAL OUTCOMES OF COVID-19 PATIENTS AT PRIVATE HOSPITAL IN JAKARTA
Ramatillah, D. L., Isnaini, S.
10.1101/2020.10.14.20212449 — Posted: 2020-10-16
shinyCurves, a shiny web application to analyse multisource qPCR amplification data: a COVID 19 case study
Olaechea-Lazaro, S., Garcia-Santisteban, I., Pineda, J. R., Badiola, I., Alonso, S., Bilbao, J. R., Fernandez-Jimenez, N.
10.1101/2020.10.14.20212381 — Posted: 2020-10-16
Ongoing Adaptive Evolution and Globalization of Sars-Cov-2
Rochman, N. D., Wolf, Y. I., Faure, G., Zhang, F., Koonin, E. V.
10.1101/2020.10.12.336644 — Posted: 2020-10-16
Shark conservation risks associated with the use of shark liver oil in SARS-CoV-2 vaccine development
Macdonald, C., Soll, J.
10.1101/2020.10.14.338053 — Posted: 2020-10-15
Design of SARS-CoV-2 RBD mRNA Vaccine Using Novel Ionizable Lipids
Elia, U., Srinivas, R., Dammes, N., Bar-Haim, E., Naidu, G. S., Makdasi, E., Cohen, O., Peer, D.
10.1101/2020.10.15.341537 — Posted: 2020-10-15
A Common Methodological Phylogenomics Framework for intra-patient heteroplasmies to infer SARS-CoV-2 sublineages and tumor clones
Utro, F., Levovitz, C., Rhrissorrakrai, K., Parida, L.
10.1101/2020.10.14.339986 — Posted: 2020-10-15
Quantitative Assays Reveal Cell Fusion at Minimal Levels of SARS-CoV-2 Spike Protein and Fusion-from-Without
Theuerkauf, S. A., Michels, A., Riechert, V., Maier, T. J., Flory, E., Cichutek, K., Buchholz, C. J.
10.1101/2020.10.15.340604 — Posted: 2020-10-15
Integrated characterization of SARS-CoV-2 genome, microbiome, antibiotic resistance and host response from single throat swabs
Lu, B., Yan, Y., Dong, L., Han, L., Liu, Y., Yu, J., Chen, J., Yi, D., Zhang, M., Wang, C., Wang, R., Wang, D., Wei, H., Liu, D., Yi, C.
10.1101/2020.10.15.340794 — Posted: 2020-10-15
Systematic analysis of innate immune antagonism reveals vulnerabilities of SARS-CoV-2
Hayn, M., Hirschenberger, M., Koepke, L., Straub, J. H., Nchioua, R., Klute, S., Prelli Bozzo, C., Aftab, W., Zech, F., Conzelmann, C., Mueller, J. A., Srinivasachar Badarinarayan, S., Stuerzel, C. M., Forne, I., Stenger, S., Conzelmann, K.-K., Muench, J., Sauter, D., Imhof, A., Kirchhoff, F., Sparrer, K. M. J.
10.1101/2020.10.15.340612 — Posted: 2020-10-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).